Fulgent Genetics (FLGT) Restructuring Costs (2025 - 2026)

Fulgent Genetics (FLGT) posted Restructuring Costs of $300000.0 for Q2 2026, down 88.46% sequentially from $2.6 million in Q1 2026.

Fulgent Genetics (FLGT) Restructuring Costs (2025 - 2026) Analysis & Trends

Fulgent Genetics has reported Restructuring Costs for 2 years, with the latest figure at $300000.0 in Q2 2026.

Quarterly Restructuring Costs changed N/A year-over-year to $300000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.5 million (changed N/A YoY) and the FY2025 annual result came in at $1.5 million, changed N/A from the prior year.
Restructuring Costs declined to $300000.0 in Q2 2026 per FLGT's latest filing, from $2.6 million in the prior quarter.
Over five years, Restructuring Costs peaked at $2.6 million in Q1 2026 and troughed at $300000.0 in Q2 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.77 Bn	209.71 Bn	8.34 Bn
2	Danaher	139.78 Bn	135.43 Bn	3.61 Bn
3	Idexx Laboratories	46.04 Bn	45.85 Bn	779.09 Mn
4	Agilent Technologies	39.68 Bn	37.88 Bn	990.00 Mn
5	Iqvia Holdings	39.34 Bn	37.26 Bn	1.44 Bn
6	Natera	38.75 Bn	37.65 Bn	696.04 Mn
7	Illumina	29.90 Bn	28.73 Bn	770.00 Mn
8	Mettler Toledo International	28.58 Bn	28.53 Bn	650.22 Mn
9	Quest Diagnostics	26.18 Bn	25.55 Bn	1.03 Bn
10	Fulgent Genetics	517.81 Mn	260.78 Mn	25.68 Mn

Download Data